154 related articles for article (PubMed ID: 36814535)
1. Effects of Two Different Doses of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates with Glucose-6-phosphate Dehydrogenase Deficiency Treated with Phototherapy: A Randomized Controlled Trial.
Farhadi R; Keyhanian E; Naderisorki M; Nadi Ghara A
Glob Pediatr Health; 2023; 10():2333794X231156055. PubMed ID: 36814535
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia.
Rezaie M; Gholami R; Jafari M; Haghighinejad H
J Paediatr Child Health; 2021 Aug; 57(8):1175-1181. PubMed ID: 33682983
[TBL] [Abstract][Full Text] [Related]
3. The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial.
Akefi R; Hashemi SM; Alinejad S; Almasi-Hashiani A
J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4075-4080. PubMed ID: 33225772
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of therapeutic effect of oral Ursodeoxycholic Acid on indirect hyperbilirubinemia in term neonates undergoing phototherapy: A randomized controlled clinical trial.
Zarkesh M; Mahdipour S; Aghili S; Jafari A; Nouri SAH; Hassanzadeh Rad A; Ghalandari M; Tabrizi M
PLoS One; 2023; 18(12):e0273516. PubMed ID: 38085723
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of ursodeoxycholic acid and multistrain synbiotic on indirect hyperbilirubinemia among neonates treated with phototherapy: A double-blind, randomized, placebo-controlled clinical trial study.
Babaie E; Hassanpour K; Aldaghi M; Sahebkar M
J Res Med Sci; 2023; 28():40. PubMed ID: 37213445
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
Zahedpasha Y; Ahmadpour-Kacho M; Hajiahmadi M; Naderi S; Kamali AA
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):557-61. PubMed ID: 18564698
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Predicting the Need for Phototherapy in Glucose 6 Phosphate Dehydrogenase-Deficient Infants in a Large Retrospective Cohort Study.
Gopagondanahalli KR; Mittal RA; Abdul Haium AA; Quek BH; Agarwal P; Daniel LM; Chua MC; Rajadurai VS
Neonatology; 2022; 119(4):494-500. PubMed ID: 35700699
[TBL] [Abstract][Full Text] [Related]
8. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Valaes T; Drummond GS; Kappas A
Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
[TBL] [Abstract][Full Text] [Related]
9. Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy.
Honar N; Ghashghaei Saadi E; Saki F; Pishva N; Shakibazad N; Hosseini Teshnizi S
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):97-100. PubMed ID: 26020375
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice.
Gharehbaghi MM; Sani AM; Refeey M
Turk J Pediatr; 2020; 62(3):424-430. PubMed ID: 32558416
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis.
Kuitunen I; Kiviranta P; Sankilampi U; Renko M
World J Pediatr; 2022 Sep; 18(9):589-597. PubMed ID: 35689782
[TBL] [Abstract][Full Text] [Related]
12. Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy.
Ughasoro MD; Adimorah GN; Chukwudi NK; Nnakenyi ID; Iloh KK; Udemba CE
Clin Exp Gastroenterol; 2019; 12():349-354. PubMed ID: 31534356
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates.
Abdel-Aziz Ali SM; Mansour Galal S; Sror SM; Hussein O; Abd-El-Haseeb Ahmed AO; Hamed EA
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):975-980. PubMed ID: 32192396
[TBL] [Abstract][Full Text] [Related]
14. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia.
Atay E; Bozaykut A; Ipek IO
J Trop Pediatr; 2006 Feb; 52(1):56-8. PubMed ID: 15917260
[TBL] [Abstract][Full Text] [Related]
15. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
Kappas A; Drummond GS; Valaes T
Pediatrics; 2001 Jul; 108(1):25-30. PubMed ID: 11433050
[TBL] [Abstract][Full Text] [Related]
16. Identifying risk of neonatal hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns in Singapore.
Shah VA; Yeo CL
Ann Acad Med Singap; 2007 Dec; 36(12):1003-9. PubMed ID: 18185880
[TBL] [Abstract][Full Text] [Related]
17. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
Murki S; Dutta S; Narang A; Sarkar U; Garewal G
J Perinatol; 2005 May; 25(5):325-30. PubMed ID: 15716985
[TBL] [Abstract][Full Text] [Related]
18. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
[TBL] [Abstract][Full Text] [Related]
19. Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials.
Lazarus G; Francie J; Roeslani RD; Saldi SRF; Oswari H
Ital J Pediatr; 2022 Oct; 48(1):179. PubMed ID: 36253867
[TBL] [Abstract][Full Text] [Related]
20. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.
Horn D; Ehret D; Gautham KS; Soll R
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013277. PubMed ID: 34228352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
